Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: Comparing neonatal, maternal, and cocooning vaccination strategies

Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: Comparing neonatal, maternal, and cocooning vaccination strategies

Highlights • Vaccinating mothers or new-borns against pertussis can reduce illness, at high costs. • If incidence increases, the cost-effectiveness of vaccination is more favourable. • The cost-effectiveness depends on the accuracy of incidence and under-reporting.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2013-11, Vol.31 (46), p.5392-5397
Hauptverfasser: Lugnér, Anna K, van der Maas, Nicoline, van Boven, Michiel, Mooi, Frits R, de Melker, Hester E
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Age
Allergy and Immunology
Applied microbiology
Bacterial diseases
Biological and medical sciences
cost effectiveness
Cost-Benefit Analysis
Cost-utility
Costs
Ent and stomatologic bacterial diseases
Families & family life
Female
Fundamental and applied biological sciences. Psychology
health care costs
Human bacterial diseases
Humans
immunity
Infant
Infant, Newborn
Infants
Infections
Infectious diseases
Male
Medical sciences
Microbiology
Models, Statistical
Mothers
Multiple births
neonates
Netherlands - epidemiology
Pertussis Vaccine - administration & dosage
Pertussis Vaccine - economics
Pregnancy
Public health
Quality of life
quality-adjusted life year
Vaccination
Vaccination - economics
Vaccination - methods
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Whooping cough
Whooping Cough - economics
Whooping Cough - epidemiology
Whooping Cough - prevention & control
Womens health
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Vaccinating mothers or new-borns against pertussis can reduce illness, at high costs. • If incidence increases, the cost-effectiveness of vaccination is more favourable. • The cost-effectiveness depends on the accuracy of incidence and under-reporting.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2013.09.028